BiotechTube
Home/Pipeline/SR2162

SR2162

Not Specified

IND ApprovedApproved

Key Facts

Indication
Not Specified
Phase
IND Approved
Status
Approved
Company
SIMR (Australia) Biotech

About SIMR (Australia) Biotech

SIMR Biotech is a clinical-stage biopharma company developing novel drugs for pain, inflammation, and CNS diseases through a patient-data-driven translational platform.

View full company profile

Therapeutic Areas

MetabolicInflammationCentral Nervous System

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
Collaborative Program with FerringPharmaBiomeResearch